ATE311870T1 - Liposomformulationen mit busulphan - Google Patents
Liposomformulationen mit busulphanInfo
- Publication number
- ATE311870T1 ATE311870T1 AT99931721T AT99931721T ATE311870T1 AT E311870 T1 ATE311870 T1 AT E311870T1 AT 99931721 T AT99931721 T AT 99931721T AT 99931721 T AT99931721 T AT 99931721T AT E311870 T1 ATE311870 T1 AT E311870T1
- Authority
- AT
- Austria
- Prior art keywords
- formulations
- busulphan
- parenteral administration
- liposome formulations
- encapsulated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Insulating Materials (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8975998P | 1998-06-18 | 1998-06-18 | |
SE9802197A SE9802197D0 (sv) | 1998-06-18 | 1998-06-18 | Formulations of busulphan |
PCT/SE1999/001093 WO1999065481A1 (en) | 1998-06-18 | 1999-06-17 | Liposomal formulations of busulphan |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE311870T1 true ATE311870T1 (de) | 2005-12-15 |
Family
ID=26663332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99931721T ATE311870T1 (de) | 1998-06-18 | 1999-06-17 | Liposomformulationen mit busulphan |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1089727B8 (de) |
JP (1) | JP2002518322A (de) |
AT (1) | ATE311870T1 (de) |
AU (1) | AU4815699A (de) |
DE (1) | DE69928805T2 (de) |
WO (1) | WO1999065481A1 (de) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1338702C (en) * | 1987-03-05 | 1996-11-12 | Lawrence D. Mayer | High drug:lipid formulations of liposomal- antineoplastic agents |
EP0660714B1 (de) * | 1991-06-18 | 2003-07-02 | ImaRx Pharmaceutical Corp. | Neue liposomale arzneimittelfreisetzungssysteme |
EP0546951A1 (de) * | 1991-12-13 | 1993-06-16 | The Liposome Company, Inc. | Kombination von im Liposomen verkapselten antineoplastischen Mitteln wie Doxorubicin, mit Kolonie-stimulierenden Faktoren |
US5430057A (en) * | 1993-09-30 | 1995-07-04 | Board Of Regents, The University Of Texas System | Parenteral busulfan for treatment of malignant disease |
-
1999
- 1999-06-17 EP EP99931721A patent/EP1089727B8/de not_active Expired - Lifetime
- 1999-06-17 WO PCT/SE1999/001093 patent/WO1999065481A1/en active IP Right Grant
- 1999-06-17 DE DE69928805T patent/DE69928805T2/de not_active Expired - Lifetime
- 1999-06-17 AU AU48156/99A patent/AU4815699A/en not_active Abandoned
- 1999-06-17 JP JP2000554361A patent/JP2002518322A/ja active Pending
- 1999-06-17 AT AT99931721T patent/ATE311870T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1999065481A1 (en) | 1999-12-23 |
JP2002518322A (ja) | 2002-06-25 |
DE69928805D1 (en) | 2006-01-12 |
EP1089727B8 (de) | 2006-03-08 |
DE69928805T2 (de) | 2006-08-31 |
EP1089727B1 (de) | 2005-12-07 |
EP1089727A1 (de) | 2001-04-11 |
AU4815699A (en) | 2000-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL347671A1 (en) | Compounds and compositions for delivering active agents | |
EP1100522A4 (de) | Verabreichung aktiver wirkstoffe über die lunge | |
HK1034183A1 (en) | Galenic formulations of meloxicam for oral administration. | |
MXPA01008611A (es) | Compuestos y composiciones para suministrar agentes activos. | |
DE60038183D1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
IL166527A0 (en) | Macrolide compounds endowed with antiinflammatory activity | |
HUP0204170A3 (en) | 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient | |
DE69713152D1 (de) | Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen | |
DZ2887A1 (fr) | Dérivés d'azétidine, leur préparation et les médicaments les contenant. | |
NO20014035L (no) | System for oral administrasjon av medikament | |
IL153297A0 (en) | Compounds and compositions for delivering active agents | |
HUP0203312A3 (en) | Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use | |
ATE399171T1 (de) | Camptothecinanaloge und deren zubereitungsmethoden | |
UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
BR0012429A (pt) | Fórmulações para il-11 | |
MY128362A (en) | Spontaneously dispersible n-benzoyl staurosporine compositions | |
MY113203A (en) | Lyophilizate of lipid complex of water insoluble camptothecins | |
ITMI20022292A1 (it) | 9a-azalidi ad attivita' antiinfiammatoria. | |
AU5290199A (en) | Erythromycin derivatives with antibiotic activity | |
AU9270598A (en) | Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates | |
ATE311870T1 (de) | Liposomformulationen mit busulphan | |
SE9902742D0 (sv) | New pharmaceutical formultion | |
AU5685300A (en) | Solid preparations containing paroxetine | |
IT1257000B (it) | Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono. | |
ATE254625T1 (de) | Eythromycinderivat mit antibiotischer aktvität |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |